Hyperglycemia, oxidative stress, inflammation, and exogenous sources of MGO all lead to elevated MGO levels and reduced glyoxalase 1 (Glo1) activity, and an MGO-Glo1 imbalance will lead to vascular dysfunction (77). This evidence concerns the gene GLO1 and Hyperglycemia.